Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream |
| |
| Authors: | Andac Salman MD Gonca Sarac MD Burce Can Kuru MD Leyla Cinel MD Ayse Deniz Yucelten MD Tulin Ergun MD |
| |
| Affiliation: | 1. Department of Dermatology, School of Medicine, Marmara University, Istanbul, Turkey;2. Department of Dermatology, Goztepe Training and Research Hospital, Istanbul Medeniyet University, Istanbul, Turkey;3. Department of Pathology, School of Medicine, Marmara University, Istanbul, Turkey |
| |
| Abstract: | Acquired progressive lymphangioma (APL), or benign lymphangioendothelioma, is an unusual entity derived from vascular structures. Clinically and histopathologically it may resemble Kaposi's sarcoma and well‐differentiated angiosarcoma, causing a diagnostic problem. We report an individual with APL initially diagnosed with Kaposi's sarcoma who underwent unnecessary laboratory testing. Imiquimod 5% cream stopped the progression of the lesion. Awareness of this rare entity may prevent patients from undergoing excessive testing. Imiquimod may be used as a safe, effective treatment option. |
| |
| Keywords: | dermatopathology hemangiomas/vascular tumors topical therapy |
|
|
